Literature DB >> 2743323

Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry.

M Ponz de Leon1, R Sassatelli, C Sacchetti, G Zanghieri, A Scalmati, L Roncucci.   

Abstract

The familial occurrence of tumors has been investigated in 389 subjects with colorectal cancer by reviewing the clinical data and the genealogical tree of all patients registered in 1984-1986, in the Local Health District, for malignancies of the large bowel. Among first-degree relatives of the registered patients there were 89 cases of colorectal cancer as opposed to 19 in a hospital-based control group matched for age and sex [odds ratio (OR), 7.5, P less than 0.001]. This excess of neoplasms among relatives was particularly evident in siblings (60 versus 7, OR 14.7, P less than 0.001) but it was observed also in parents (27 versus 12, OR 4.2, P less than 0.01). Besides colorectal cancer there was no significant excess of other types of tumor in case families, whereas lung tumors tended to be more frequent in control relatives (32 versus 17). Almost half of the registered patients (182 out of 389) had one or more cases of cancer of any sites among relatives; similarly, in 68 there were one or more relatives affected by (or deceased for) colorectal cancer. Moreover, in 27 patients (7.0%) there were at least three cancers of any sites among relatives and in 15 the excess (two or more) was limited to neoplasms of the large bowel. In patients without or with only one neoplasm among relatives, cancers were mainly located in the left colon; however, cancer of the right colon became relatively more frequent in patients with two or more tumors in close relatives. In conclusion, the present study suggests that in approximately 15-20% of patients registered for colorectal cancer one or more first-degree relatives are affected by neoplasms of the large bowel. This familial occurrence of intestinal malignancies (but not of tumors of other organs) strongly suggests a genetic susceptibility to colorectal cancer in a fraction of these patients. Moreover, in a further subgroup of individuals (approximately 5% of all cases) the familial aggregation of two or more cases of colorectal cancer among relatives (besides the proband) and the frequent location of tumors in the right colon make the diagnosis of Lynch syndrome extremely probable.

Entities:  

Mesh:

Year:  1989        PMID: 2743323

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  DNA mismatch repair genes and colorectal cancer.

Authors:  J M Wheeler; W F Bodmer; N J Mortensen
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome.

Authors:  Valeria Barresi; Carmela Di Gregorio; Luca Regiani-Bonetti; Maurizio Ponz-De Leon; Gaetano Barresi; Enrica Vitarelli
Journal:  Virchows Arch       Date:  2010-06-08       Impact factor: 4.064

3.  Clinical features of colorectal cancer patients in advanced age: a population-based approach.

Authors:  Stefania Maffei; Alessandra Colantoni; Shaniko Kaleci; Piero Benatti; Ester Tesini; Maurizio Ponz de Leon
Journal:  Intern Emerg Med       Date:  2015-10-19       Impact factor: 3.397

4.  Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta.

Authors:  P J Westlake; H E Bryant; S A Huchcroft; L R Sutherland
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

5.  Genetic implications of double primary cancers of the colorectum and endometrium.

Authors:  T Pal; T Flanders; M Mitchell-Lehman; A MacMillan; J S Brunet; S A Narod; W D Foulkes
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

6.  The genotype of the transporter associated with antigen processing gene affects susceptibility to colorectal cancer in Japanese.

Authors:  Takenori Yamauchi; Shouhei Takeuchi; Naoki Maehara; Yoshiki Kuroda
Journal:  Environ Health Prev Med       Date:  2014-05-07       Impact factor: 3.674

7.  Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients.

Authors:  Dagmara Dymerska; Pablo Serrano-Fernández; Janina Suchy; Andrzej Pławski; Ryszard Słomski; Krzysztof Kaklewski; Rodney J Scott; Jacek Gronwald; Józef Kładny; Tomasz Byrski; Tomasz Huzarski; Jan Lubiński; Grzegorz Kurzawski
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

8.  Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon.

Authors:  W D Foulkes; N Bolduc; D Lambert; O Ginsburg; L Olien; D W Yandell; P N Tonin; S A Narod
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

9.  Frequency of replication errors in colorectal cancer and their association with family history.

Authors:  S R Brown; P J Finan; L Cawkwell; P Quirke; D T Bishop
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

10.  Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer?

Authors:  S R Brown; P J Finan; D T Bishop
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.